Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence? The case of Greece. Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Razavi H, Hatzakis A. J Gastroenterol Hepatol. 2016 Jul 12. doi: 10.1111/jgh.13485. [Epub ahead of print] Για να δείτε το άρθρο πιέστε εδώ
ΛεπτομέρειεςEvaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event. Agiasotelli D, Alexopoulou A, Vasilieva L, Kalpakou G, Papadaki S, Dourakis SP. Hepatol Res. 2016 May;46(6):514-20. doi: 10.1111/hepr.12582. Epub 2015 Oct 6. Για να δείτε το άρθρο πιέστε εδώ
ΛεπτομέρειεςDiscontinuation of oral antivirals in chronic hepatitis B: A systematic review. Papatheodoridis G, Vlachogiannakos I, Cholongitas E, Wursthorn K, Thomadakis C, Touloumi G, Petersen J. Hepatology. 2016 May;63(5):1481-92. doi: 10.1002/hep.28438. Epub 2016 Mar 4. Για να δείτε το άρθρο πιέστε εδώ
ΛεπτομέρειεςExtensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, Toutouza M, Dourakis SP. World J Gastroenterol. 2016 Apr 21;22(15):4049-56. doi: 10.3748/wjg.v22.i15.4049. Για να δείτε το άρθρο πιέστε εδώ
ΛεπτομέρειεςTGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment. Argentou N, Germanidis G, Hytiroglou P, Apostolou E, Vassiliadis T, Patsiaoura K, Sideras P, Germenis AE, Speletas M. Inflamm Res. 2016 May;65(5):355-65. doi: 10.1007/s00011-016-0921-6. Epub 2016 Feb 9. Για να δείτε το άρθρο πιέστε εδώ
ΛεπτομέρειεςBackground & Aims: Risk scores for hepatocellular carcinoma (HCC) developed in Asians offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This nine center cohort study aimed to develop and validate an accurate HCC risk score in Caucasian CHB patients treated with the current oral antivirals, entecavir/tenofovir. Για να δείτε τη συνέχεια πιέστε…
ΛεπτομέρειεςBackground Front-line therapy with mycophenolate mofetil (MMF) in autoimmune hepatitis (AIH) has shown high on-treatment remission rates. Για να δείτε τη συνέχεια πιέστε εδώ
ΛεπτομέρειεςAutoimmune hepatitis remains a major diagnostic and therapeutic challenge. The clinician, the hepato-pathologist and the laboratory personnel need to become more familiar with different expressions of the disease, interpretation of liver histology and autoimmune serology.
Λεπτομέρειες
